Date Published
Country
Source
Videos
close
- Reset All Filters
- 22 results found
- x United States
- x 2018
- x Cancer
- x International-Comparisons
-
Politicians Finally Take Action After Citizen Outrage Over Drug Prices Grows
Democratic Senator Jeff Merkley has introduced new legislation that would finally punish drug companies for price gouging American consumers. -
American Woman's Medication Costs 10% of US Price in Spain
This woman got her medication in Spain for just 10% of its cost in the U.S. It's time we pass meaningful legislation to stop letting pharma rip us off. -
The Sustainability of Rising Drug Prices in Oncology
The sustainability of the field of oncology as drug prices continue to rise. -
Potential New Reimbursement Models for New, High-Cost Therapies
There’s a number of different ways that payers are looking at new reimbursement models for new, high-cost therapies. -
Cancer-Fighting Foods
Dr. Dawn Mussallem, a breast cancer expert and cancer survivor, shares information about foods that fight and prevent cancer.Comments
-
Expecting More Concrete Moves
Pfizer CEO says tying drug prices to foreign countries is not good for patients. -
Trump Unveils Plan to Reduce Medicare Drug Prices
President Trump on Oct. 25 announced a plan to reduce Medicare drug prices and take “aim at global freeloading.” -
Finding a Cure for the Cost of Durable Therapies
"Curative" is not a word that we can use very often in medicine, especially when talking about diseases such as cancer and rare genetic disorders. -
Cancer Drug Pricing and the Last Mile of Innovation
The National Academy of Medicine hosted its 48th Annual Meeting in Washington, DC. -
Many Breast Cancer Patients Struggle Financially with Treatment Costs
According to the American Cancer Society, one in eight women in the U.S. will develop breast cancer in their lifetime. -
What Kind of Savings are Possible?
Lowering Pharmaceutical costs under U.S. single-payer financing. -
Economic Trade-offs in Cancer Drug Pricing
In the last 5 years, cancer mortality has dropped 1.5 % equaling a financial reduction of approximately $750 Billion. -
Value and Cost in MM Treatment
Multiple myeloma (MM) is an expensive cancer to treat, with costly drugs that are often used in combination. -
The Guy Who Made A Killing
As a drug company CEO, Bob Hugin made more than $100 million dollars by doubling the price of a cancer drug, forcing some families to take out home loans to afford his drugs just to stay alive. -
Trump's Plan to Cut High Drug Prices: Can It Succeed?
Health policy scholar breaks it down.